THE USE OF DEXTRAN DERIVATIVES IN PREVENTING OR TREATING ANEMIA.
摘要
<p>The present invention relates to the use of modified dextran to prevent or treat anemia in mammals by increasing the number of red blood cells and/or hemoglobin and/or the hematocrit levels in blood. Dextran is modified by substitution of the cationic compound containing amino and/or ammonium groups.</p>
申请公布号
WO2013157967(A1)
申请公布日期
2013.10.24
申请号
WO2013PL00049
申请日期
2013.04.11
申请人
UNIWERSYTET JAGIELLONSKI;MEDICAL UNIVERSITY OF BIALYSTOK
